关注
RICHARD DONKOR
RICHARD DONKOR
BPEI; Retina Consultants of America; Retina Associates of Cleveland Inc; University of Waterloo
在 miami.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Keratoconus in Africa: a systematic review and meta‐analysis
PK Akowuah, E Kobia‐Acquah, R Donkor, J Adjei‐Anang, ...
Ophthalmic and Physiological Optics 41 (4), 736-747, 2021
282021
Repetitive visual cortex transcranial random noise stimulation in adults with amblyopia
R Donkor, AE Silva, C Teske, M Wallis-Duffy, AP Johnson, B Thompson
Scientific Reports 11 (1), 3029, 2021
222021
Attitudes and beliefs of undergraduate students to spectacle wear in Ghana
E Kobia-Acquah, E Essien, R Ablordeppey, R Donkor, ...
AOVS 8, 00264, 2018
92018
Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration
JM Coney, R Zubricky, SB Sinha, N Sonbolian, L Zhou, TP Hull, SA Lewis, ...
International Journal of Retina and Vitreous 9 (1), 8, 2023
72023
Contact lens complications among wearers in Ghana
E Kobia-Acquah, PK Akowuah, EK Antwi-Adjei, PM Forkuo, NY Koomson, ...
Contact Lens and Anterior Eye 44 (1), 67-71, 2021
62021
Prevalence of meibomian gland dysfunction in Africa: a systematic review and meta-analysis of observational studies
PK Akowuah, E Kobia-Acquah, R Donkor, C Arthur, EN Senanu, ...
Ophthalmic Epidemiology 29 (4), 374-383, 2022
52022
Analysis of urgent follow up visits and complications after intravitreal injections: a retrospective cohort study
A Miller, MA Wilneff, A Yazji, E Petrinec, M Carbone, C Miller, ...
International Journal of Retina and Vitreous 8 (1), 8, 2022
52022
Assessment of ocular surface disease in glaucoma patients in Ghana
E Kobia-Acquah, GAP Gyekye, EK Antwi-Adjei, NY Koomson, F Cobbina, ...
Journal of Glaucoma 30 (2), 180-186, 2021
52021
Contact lens complications among wearers in Ghana
E Kobia-Acquah, PM Forkuo, EK Antwi-Adjei, SO Odotei, E Alabi, ...
Contact Lens and Anterior Eye 42 (6), e11, 2019
42019
Incidence and risk factors for neutropenia after intra-arterial chemotherapy for retinoblastoma
DH Lee, R Donkor, MN Parvus, MJ Dannenbaum, AC Schefler
JAMA ophthalmology 141 (12), 1133-1138, 2023
32023
Injection intervals in real-world neovascular age-related macular degeneration (nAMD) switch brolucizumab (BROL) patients with at least 12 months of follow-up
R Zubricky, J McCoy, SB Sinha, N Sonbolian, L Zhou, R Donkor, ...
Investigative Ophthalmology & Visual Science 63 (7), 1313–F0147-1313–F0147, 2022
32022
Prevalence of keratoconus in Ghana: a hospital-based study of tertiary eye care facilities
E Kobia-Acquah, EN Senanu, EK Antwi-Adjei, DP Appiah, DB Kumah, ...
European Journal of Ophthalmology 32 (6), 3185-3194, 2022
22022
Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab
R Zubricky, J McCoy, R Donkor, DG Miller, N Sonbolian, A Heaney, ...
Ophthalmology and Therapy 12 (5), 2397-2408, 2023
12023
Strabismus and amblyopia in Africa–a systematic review and meta-analysis
PK Akowuah, S Adade, A Nartey, E Owusu, R Donkor, ...
Strabismus 31 (1), 31-44, 2023
12023
Multi-session visual cortex transcranial random noise stimulation in adults with amblyopia
R Donkor, AE Silva, C Teske, M Wallis-Duffy, A Johnson, B Thompson
bioRxiv, 679662, 2019
12019
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents
JM Coney, JE McCoy, S Buxy Sinha, N Sonbolian, L Zhou, TP Hull, ...
Clinical Ophthalmology, 3601-3611, 2023
2023
Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes
M Abdulaal, R Donkor, J Robertson, S Lewis, DG Miller, J Schartman, ...
Canadian Journal of Ophthalmology, 2023
2023
Real-world frequency and outcomes of intraocular inflammation-related adverse events in eyes with neovascular age-related macular degeneration treated with brolucizumab
JE McCoy, R Zubricky, R Donkor, DG Miller, N Sonbolian, A Heaney, ...
Investigative Ophthalmology & Visual Science 64 (8), 2216-2216, 2023
2023
Real-world clinical outcomes after sustained delivery of the 0.19 mg fluocinolone acetonide (FAc) implant for treatment of diabetic macular edema (DME)
S Godel, D Oncel, R Donkor, JM Coney
Investigative Ophthalmology & Visual Science 64 (8), 2641-2641, 2023
2023
Characterization of real-world neovascular age-related macular degeneration (nAMD) switch patients treated with brolucizumab (BROL) alternating with other anti-Vascular …
J McCoy, R Zubricky, SB Sinha, N Sonbolian, L Zhou, R Donkor, ...
Investigative Ophthalmology & Visual Science 63 (7), 1314–F0148-1314–F0148, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20